Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function

REFERENCES

• Bertwistle, D., F. Zindy, C. J. Sherr, and M. F. Roussel. 2004. Monoclonal antibodies to the mouse p19ARF tumor suppressor protein. Hybridoma Hybridomics 23:293–300.
   PubMedGoogle Scholar
• Bertwistle, D., M. Sugimoto, and C. J. Sherr. 2004. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol. Cell. Biol. 24:985–996.
   PubMed Web of Science ®Google Scholar
• Biggiogera, M., K. Burki, S. H. Kaufmann, J. H. Shaper, N. Gas, F. Amalric, and S. Fakan. 1990. Nucleolar distribution of proteins B23 and nucleolin in mouse preimplantation embryos as visualized by immunoelectron microscopy. Development 110:1263–1270.
   PubMed Web of Science ®Google Scholar
• Borer, R. A., C. F. Lehner, H. M. Eppenberger, and E. A. Nigg. 1989. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379–390.
   PubMed Web of Science ®Google Scholar
• Carnero, A., J. D. Hudson, C. M. Price, and D. H. Beach. 2000. p16(INK4A) and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol. 2:148–155.
   PubMedGoogle Scholar
• Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Chiarle, R., J. Z. Gong, I. Guasparri, A. Pesci, J. Cai, J. Liu, W. J. Simmons, G. Dhall, J. Howes, R. Piva, and G. Inghirami. 2003. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors. Blood 101:1919–1927.
   PubMed Web of Science ®Google Scholar
• Colombo, E., J. C. Marine, D. Danovi, B. Falini, and P. G. Pelicci. 2002. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat. Cell Biol. 4:529–533.
   PubMed Web of Science ®Google Scholar
• Daniely, Y., D. D. Dimitrova, and J. A. Borowiec. 2002. Stress-dependent nucleolin mobilization mediated by p53-nucleolin complex formation. Mol. Cell. Biol. 22:6014–6022.
   PubMedGoogle Scholar
• Datta, A., A. Nag, and P. Raychaudhuri. 2002. Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF. Mol. Cell. Biol. 22:8398–8408.
   PubMedGoogle Scholar
• David-Pfeuty, T., and Y. Nouvian-Dooghe. 2002. Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function. Oncogene 21:6779–6790.
   PubMedGoogle Scholar
• Derenzini, M. 2000. The AgNORs. Micron 31:117–120.
   PubMed Web of Science ®Google Scholar
• de Stanchina, E., M. E. Mccurrach, F. Zindy, S. Y. Shieh, G. Ferbeyre, A. V. Samuelson, C. Prives, M. F. Roussel, C. J. Sherr, and S. W. Lowe. 1998. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev. 12:2434–2442.
   PubMed Web of Science ®Google Scholar
• Duro, D., O. Bernard, V. Della Valle, R. Berger, and C. J. Larsen. 1995. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies. Oncogene 11:21–29.
   PubMed Web of Science ®Google Scholar
• Eymin, B., L. Karayan, P. Seite, C. Brambilla, E. Brambilla, C. J. Larsen, and S. Gazzeri. 2001. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 20:1033–1041.
   PubMed Web of Science ®Google Scholar
• Fatyol, K., and A. A. Szalay. 2001. The p14arf tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription. J. Biol. Chem. 276:28421–28429.
   PubMed Web of Science ®Google Scholar
• Garcia, S. N., and L. Pillus. 1999. Net results of nucleolar dynamics. Cell 97:825–828.
   PubMed Web of Science ®Google Scholar
• Giaccia, A. J., and M. B. Kastan. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973–2983.
   PubMed Web of Science ®Google Scholar
• Ginisty, H., H. Sicard, B. Roger, and P. Bouvet. 1999. Structure and functions of nucleolin. J. Cell Sci. 112:761–772.
   PubMed Web of Science ®Google Scholar
• Guo, Q. M., R. L. Malek, S. Kim, C. Chiao, M. He, M. Ruffy, K. Sanka, N. H. Lee, C. V. Dang, and E. T. Liu. 2000. Identification of c-Myc responsive genes using rat cDNA microarray. Cancer Res. 60:5922–5928.
   PubMed Web of Science ®Google Scholar
• Hasan, M., T. Yaguchi, T. Sugihara, P. K. R. Kumar, K. Taira, R. R. Reddel, S. C. Kaul, and R. Wadhwa. 2002. CARF is a novel protein that cooperates with mouse p19arf (human p14arf) in activating p53. J. Biol. Chem. 277:37765.
   PubMedGoogle Scholar
• Henry, M. K., J. T. Lynch, A. K. Eapen, and F. W. Quelle. 2001. DNA damage-induced cell-cycle arrest of hematopoietic cells is overridden by activation of the PI-3 kinase/Akt signaling pathway. Blood 98:834–841.
   PubMedGoogle Scholar
• Hingorani, K., A. Szebeni, and M. O. J. Olson. 2000. Mapping the functional domains of nucleolar protein B23. J. Biol. Chem. 275:24451–24457.
   PubMed Web of Science ®Google Scholar
• Honda, R., and H. Yasuda. 1999. Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J. 18:22–27.
   PubMed Web of Science ®Google Scholar
• Itahana, K., K. P. Bhat, A. W. Jin, Y. Itahana, D. Hawke, R. Kobayashi, and Y. P. Zhang. 2003. Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Mol. Cell 12:1151–1164.
   PubMed Web of Science ®Google Scholar
• Jackson, M. W., M. S. Lindstrom, and S. J. Berberich. 2001. MdmX binding to ARF affects Mdm2 protein stability and p53 transactivation. J. Biol. Chem. 276:25336–25341.
   PubMedGoogle Scholar
• Jiang, P. S., and B. Y. M. Yung. 1999. Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis. Biochem. Biophys. Res. Commun. 257:865–870.
   PubMedGoogle Scholar
• Kalinichenko, V. V., M. L. Major, X. Wang, V. Petrovic, J. Kuechle, H. M. Yoder, M. B. Dennewitz, B. Shin, A. Datta, P. Raychaudhuri, and R. H. Costa. 2004. Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev. 18:830–850.
   PubMed Web of Science ®Google Scholar
• Kamijo, T., J. D. Weber, G. Zambetti, F. Zindy, M. F. Roussel, and C. J. Sherr. 1998. Functional and physical interactions of the ARF tumor suppressor with p53 and mdm2. Proc. Natl. Acad. Sci. USA 95:8292–8297.
   PubMed Web of Science ®Google Scholar
• Kamijo, T., F. Zindy, M. F. Roussel, D. E. Quelle, J. R. Downing, R. A. Ashmun, G. Grosveld, and C. J. Sherr. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Korgaonkar, C., L. Zhao, M. Modestou, and D. E. Quelle. 2002. ARF function does not require p53 stabilization or Mdm2 relocalization. Mol. Cell. Biol. 22:196–206.
   PubMedGoogle Scholar
• Kuo, M. L., W. den Besten, D. Bertwistle, M. F. Roussel, and C. J. Sherr. 2004. N-terminal polyubiquitination and degradation of the Arf tumor suppressor. Genes Dev. 18:1862–1874.
   PubMed Web of Science ®Google Scholar
• Kurki, S., K. Peltonen, L. Latonen, T. M. Kiviharju, P. M. Ojala, D. Meek, and M. Laiho. 2004. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 5:465–475.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323–331.
   PubMed Web of Science ®Google Scholar
• Li, J., X. Zhang, D. P. Sejas, G. C. Bagby, and Q. Pang. 2004. Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J. Biol. Chem. 279:41275–41279.
   PubMed Web of Science ®Google Scholar
• Li, Y. P. 1997. Protein B23 is an important human factor for the nucleolar localization of the human immunodeficiency virus protein Tat. J. Virol. 71:4098–4102.
   PubMedGoogle Scholar
• Li, Y. P., R. K. Busch, B. C. Valdez, and H. Busch. 1996. C23 interacts with B23, a putative nucleolar-localization-signal-binding protein. Eur. J. Biochem. 237:153–158.
   PubMedGoogle Scholar
• Lin, A. W., and S. W. Lowe. 2001. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation. Proc. Natl. Acad. Sci. USA 98:5025–5030.
   PubMed Web of Science ®Google Scholar
• Lindstrom, M. S., U. Klangby, R. Inoue, P. Pisa, K. G. Wiman, and C. E. Asker. 2000. Immunolocalization of human p14ARF to the granular component of the interphase nucleolus. Exp. Cell Res. 256:400–410.
   PubMed Web of Science ®Google Scholar
• Llanos, S., P. A. Clark, J. Rowe, and G. Peters. 2001. Stabilisation of p53 by p14ARF without relocalization of Mdm2 to the nucleolus. Nat. Cell Biol. 3:445–452.
   PubMed Web of Science ®Google Scholar
• Lohrum, M. A., M. Ashcroft, M. H. Kubbutat, and K. H. Vousden. 2000. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization. Curr. Biol. 10:539–542.
   PubMed Web of Science ®Google Scholar
• Lohrum, M. A. E., M. Ashcroft, M. H. G. Kubbutat, and K. H. Vousden. 2000. Identification of a cryptic nucleolar-localization signal in MDM2. Nat. Cell Biol. 2:179–181.
   PubMed Web of Science ®Google Scholar
• Lowe, S. W., and C. J. Sherr. 2003. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr. Opin. Gen. Dev. 13:77–83.
   PubMed Web of Science ®Google Scholar
• Mao, L., A. Merlo, G. Bedi, G. I. Shapiro, C. D. Edwards, B. J. Rollins, and D. Sidransky. 1995. A novel p16INK4A transcript. Cancer Res. 55:2995–2997.
   PubMed Web of Science ®Google Scholar
• Martelli, F., T. Hamilton, D. P. Silver, N. E. Sharpless, N. Bardeesy, M. Rokas, R. A. DePinho, D. M. Livingston, and S. R. Grossman. 2001. p19ARF targets certain E2F species for degradation. Proc. Natl. Acad. Sci. USA 98:4455–4460.
   PubMed Web of Science ®Google Scholar
• McKeller, R. N., J. L. Fowler, J. J. Cunningham, N. Warner, R. J. Smeyne, F. Zindy, and S. X. Skapek. 2002. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development. Proc. Natl. Acad. Sci. USA 99:3848–3853.
   PubMed Web of Science ®Google Scholar
• Menendez, S., Z. Khan, D. W. Coomber, D. P. Lane, M. Higgins, M. M. Koufali, and S. Lain. 2003. Oligomerization of the human ARF tumor suppressor and its response to oxidative stress. J. Biol. Chem. 278:18720–18729.
   PubMedGoogle Scholar
• Midgley, C. A., J. M. P. Desterro, M. K. Saville, S. Howard, A. Sparks, R. T. Hay, and D. P. Lane. 2000. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19:2312–2323.
   PubMed Web of Science ®Google Scholar
• Modestou, M., V. Puig-Antich, C. Korgaonkar, A. Eapen, and D. E. Quelle. 2001. The ARF tumor suppressor inhibits growth through p21-dependent and p21-independent pathways. Cancer Res. 61:3145–3150.
   PubMedGoogle Scholar
• Momand, J., H. H. Wu, and G. Dasgupta. 2000. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242:15–29.
   PubMed Web of Science ®Google Scholar
• Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378:203–206.
   PubMed Web of Science ®Google Scholar
• Nozawa, Y., N. vanBelzen, A. C. J. vanderMade, W. N. M. Dinjens, and F. T. Bosman. 1996. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa. J. Pathol. 178:48–52.
   PubMed Web of Science ®Google Scholar
• Okuda, M., H. F. Horn, P. Tarapore, Y. Tokuyama, A. G. Smulian, P. K. Chan, E. S. Knudsen, I. A. Hofmann, J. D. Snyder, K. E. Bove, and K. Fukasawa. 2000. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103:127–140.
   PubMed Web of Science ®Google Scholar
• O'Leary, K. A., S. M. Mendrysa, A. Vaccaro, and M. E. Perry. 2004. Mdm2 regulates p53 independently of p19ARF in homeostatic tissues. Mol. Cell. Biol. 24:186–191.
   PubMed Web of Science ®Google Scholar
• Olson, D. C., V. Marechal, J. Momand, J. Chen, C. Romocki, and A. J. Levine. 1993. Identification and characterization of multiple mdm-2 proteins and mdm-2-p53 protein complexes. Oncogene 8:2353–2360.
   PubMed Web of Science ®Google Scholar
• Olson, M. O. J. 16 March 2004, posting date. Sensing cellular stress: another new function for the nucleolus? Science STKE 2004:e10. [Online.] doi:10.1126/stke.2242004pe10.
   Google Scholar
• Pan, W., A. Datta, G. R. Adami, P. Raychaudhuri, and S. Bagchi. 2003. p19ARF inhibits the functions of the HPV16 E7 oncoprotein. Oncogene 22:5496–5503.
   PubMedGoogle Scholar
• Pomerantz, J., N. Schreiberagus, N. J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H. W. Lee, C. Cordoncardo, and R. A. DePinho. 1998. The INK4a tumor suppressor gene product, p19ARF, interacts with mdm2 and neutralizes mdm2s inhibition of p53. Cell 92:713–723.
   PubMed Web of Science ®Google Scholar
• Quelle, D. E., F. Zindy, R. A. Ashmun, and C. J. Sherr. 1995. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83:993–1000.
   PubMed Web of Science ®Google Scholar
• Raveh, T., G. Droguett, M. S. Horwitz, R. A. DePinho, and A. Kimchi. 2001. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat. Cell Biol. 3:1–7.
   PubMed Web of Science ®Google Scholar
• Redner, R. L. 2002. Variations on a theme: the alternate translocations in APL. Leukemia 16:1927–1932.
   PubMed Web of Science ®Google Scholar
• Ries, S. J., C. H. Brandts, A. S. Chung, C. H. Biederer, B. C. Hann, E. M. Lipner, F. McCormick, and W. M. Korn. 2000. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015). Nat. Med. 6:1128–1133.
   PubMed Web of Science ®Google Scholar
• Rizos, H., E. Diefenbach, P. Badhwar, S. Woodruff, T. M. Becker, R. J. Rooney, and R. F. Kefford. 2003. Association of p14(ARF) with the p120(E4F) transcriptional repressor enhances cell cycle inhibition. J. Biol. Chem. 278:4981–4989.
   PubMedGoogle Scholar
• Rodway, H., S. Llanos, J. Rowe, and G. Peters. 2004. Stability of nucleolar versus nonnucleolar forms of human p14(ARF). Oncogene 23:6186–6192.
   PubMedGoogle Scholar
• Ruas, M., and G. Peters. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378:F115–F177.
   PubMed Web of Science ®Google Scholar
• Rubbi, C. P., and J. Milner. 2003. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 22:6068–6077.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 2001. The INK4a/ARF network in tumour suppression. Nat. Rev. Mol. Cell. Biol. 2:731–737.
   PubMed Web of Science ®Google Scholar
• Stone, S., P. Jiang, P. Dayananth, S. V. Tavtigian, H. Katcher, D. Parry, G. Peters, and A. Kamb. 1995. Complex structure and regulation of the P16 (MTS1) locus. Cancer Res. 55:2988–2994.
   PubMed Web of Science ®Google Scholar
• Stott, F. J., S. Bates, M. C. James, B. B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K. H. Vousden, and G. Peters. 1998. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:5001–5014.
   PubMed Web of Science ®Google Scholar
• Subong, E. N. P., M. J. Shue, J. I. Epstein, J. V. Briggman, P. K. Chan, and A. W. Partin. 1999. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO: 4-216) recognizes nucleophosmin/B23. Prostate 39:298–304.
   PubMed Web of Science ®Google Scholar
• Sugihara, T., S. C. Kaul, J. Y. Kato, R. R. Reddel, H. Nomura, and R. Wadhwa. 2001. Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway. J. Biol. Chem. 276:18649–18652.
   PubMedGoogle Scholar
• Sugimoto, M., M. L. Kuo, M. F. Roussel, and C. J. Sherr. 2003. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Mol. Cell 11:415–424.
   PubMed Web of Science ®Google Scholar
• Szebeni, A., and M. O. J. Olson. 1999. Nucleolar protein B23 has molecular chaperone activities. Protein Sci. 8:905–912.
   PubMed Web of Science ®Google Scholar
• Tao, W. K., and A. J. Levine. 1999. p19ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl. Acad. Sci. USA 96:6937–6941.
   PubMed Web of Science ®Google Scholar
• Valdez, B. C., L. Perlaky, D. Henning, Y. Saijo, P. K. Chan, and H. Busch. 1994. Identification of the nuclear and nucleolar localization signals of the protein p120-interaction with translocation protein B23. J. Biol. Chem. 269:23776–23783.
   PubMedGoogle Scholar
• Weber, J. D., J. R. Jeffers, J. E. Rehg, D. H. Randle, G. Lozano, M. F. Roussel, C. J. Sherr, and G. P. Zambetti. 2000. p53-independent functions of the p19ARF tumor suppressor. Genes Dev. 14:2358–2365.
   PubMed Web of Science ®Google Scholar
• Weber, J. D., M. L. Kuo, B. Bothner, E. L. DiGiammarino, R. W. Kriwacki, Roussel, M. F., and C. J. Sherr. 2000. Cooperative signals governing ARF-Mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20:2517–2528.
   PubMed Web of Science ®Google Scholar
• Weber, J. D., L. J. Taylor, M. F. Roussel, C. J. Sherr, and D. Bar-Sagi. 1999. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell Biol. 1:20–26.
   PubMed Web of Science ®Google Scholar
• Wu, M. H., J. H. Chang, and B. Y. M. Yung. 2002. Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression. Carcinogenesis 23:93–100.
   PubMedGoogle Scholar
• YonedaKato, N., A. T. Look, M. N. Kirstein, M. B. Valentine, S. C. Raimondi, K. J. Cohen, A. J. Carroll, and S. W. Morris. 1996. The t(3;5) (q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 12:265–275.
   PubMedGoogle Scholar
• Zeller, K. I., T. J. Haggerty, J. F. Barrett, Q. B. Guo, D. R. Wonsey, and C. V. Dang. 2001. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J. Biol. Chem. 276:48285–48291.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Y. Xiong, and W. G. Yarbrough. 1998. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92:725–734.
   PubMed Web of Science ®Google Scholar
• Zhao, L., T. Samuels, S. Winckler, C. Korgaonkar, V. Tompkins, M. C. Horne, and D. E. Quelle. 2003. Cyclin G1 has growth inhibitory activity linked to the ARF-Mdm2-p53 and pRb tumor suppressor pathways. Mol. Cancer Res. 1:195–206.
   PubMed Web of Science ®Google Scholar
• Zindy, F., C. M. Eischen, D. H. Randle, T. Kamijo, J. L. Cleveland, C. J. Sherr, and M. F. Roussel. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:2424–2433.
   PubMed Web of Science ®Google Scholar
• Zindy, F., D. E. Quelle, M. F. Roussel, and C. J. Sherr. 1997. Expression of the p16(INK4a) tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15:203–211.
   PubMedGoogle Scholar
• Zindy, F., R. T. Williams, T. A. Baudino, J. E. Rehg, S. X. Skapek, J. L. Cleveland, M. F. Roussel, and C. J. Sherr. 2003. Arf tumor suppressor promoter monitors latent oncogenic signals in vivo. Proc. Natl. Acad. Sci. USA 100:15930–15935.
   PubMed Web of Science ®Google Scholar